Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What information is available on company profile pages?

Company profile pages provide comprehensive information including financial statements, earnings data, analyst ratings, institutional ownership, insider trading, SEC filings, and detailed business analysis.

How do I analyze a company's financial health?

Use our financial metrics including P/E ratio, debt-to-equity, revenue growth, profit margins, and cash flow analysis to evaluate a company's financial strength and growth potential.

How do I analyze TAK stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TAK investment potential.

What is TAK stock price today?

The current TAK stock price is $15.58 as of 25 Dec '25. Get real-time TAK stock price, historical data, and price charts on Financhill.

Is TAK a good investment?

Evaluate TAK investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

What does Takeda Pharmaceutical Co., Ltd. (TAK) do?

Takeda Pharmaceutical Co., Ltd. (TAK) is a publicly traded company. View detailed company information, business model, financial statements, and corporate data on our TAK company profile page.

How to buy TAK stock?

To buy TAK stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TAK?

View detailed market capitalization data and company valuation metrics for TAK on our comprehensive analysis page.

What is the P/E ratio of TAK?

Use our fundamental analysis tools to view TAK P/E ratio and compare valuation metrics with industry peers.

What are TAK earnings?

View TAK earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Buy

70

TAK Quote, Financials, Valuation and Earnings

Last price:

$15.58

Seasonality move :

4.51%

Day range:

$15.52 - $15.62

52-week range:

$12.80 - $15.69

Dividend yield:

4.24%

P/E ratio:

197.72x

P/S ratio:

1.68x

P/B ratio:

1.02x

Volume:

1.3M

Avg. volume:

2.9M

1-year change:

18.3%

Market cap:

$49.2B

Revenue:

$30.1B

EPS (TTM):

$0.08

Period Ending	2021-03-31 FY-4	2022-03-31 FY-3	2023-03-31 FY-2	2024-03-31 FY-1	2025-03-31 Current FY
Revenue	$30.2B	$31.8B	$29.7B	$29.5B	$30.1B
Revenue Growth (YoY)	-0.39%	5.34%	-6.43%	-0.78%	1.92%

Cost of Revenues	$13.2B	$13.6B	$12.8B	$13.4B	$13.9B
Gross Profit	$17B	$18.2B	$17B	$16.1B	$16.1B
Gross Profit Margin	56.24%	57.26%	57.07%	54.53%	53.59%

R&D Expenses	$4.3B	$4.7B	$4.7B	$5B	$4.8B
Selling, General & Admin	$8.3B	$7.9B	$7.4B	$7.3B	$7.2B
Other Inc / (Exp)	$819.1M	-$1.1B	-$661.6M	-$1.2B	-$1.1B
Operating Expenses	$12.7B	$12.8B	$12.1B	$12.4B	$12B
Operating Income	$4.2B	$5.4B	$4.9B	$3.7B	$4.1B

Net Interest Expenses	$1.4B	$1.3B	$1B	$1.1B	$1.2B
EBT. Incl. Unusual Items	$3.5B	$2.8B	$2.8B	$320.3M	$1.2B
Earnings of Discontinued Ops.	--	--	--	--	--
Income Tax Expense	-$93.7M	$644.3M	$428.4M	-$632.1M	$439.1M
Net Income to Company	$3.5B	$2B	$2.3B	$998.1M	$709.4M

Minority Interest in Earnings	$1.6M	$952.2K	$155K	$899K	$1.4M
Net Income to Common Excl Extra Items	$3.5B	$2B	$2.3B	$997.2M	$709.4M

Basic EPS (Cont. Ops)	$1.13	$0.65	$0.75	$0.32	$0.22
Diluted EPS (Cont. Ops)	$1.13	$0.65	$0.75	$0.32	$0.22
Weighted Average Basic Share	$3.1B	$3.1B	$3.1B	$3.1B	$3.2B
Weighted Average Diluted Share	$3.1B	$3.2B	$3.1B	$3.2B	$3.2B

EBITDA	$9.5B	$10.6B	$9.8B	$8.7B	$9.1B
EBIT	$4.2B	$5.4B	$4.9B	$3.7B	$4.1B

Revenue (Reported)	$30.2B	$31.8B	$29.7B	$29.5B	$30.1B
Operating Income (Reported)	$4.2B	$5.4B	$4.9B	$3.7B	$4.1B
Operating Income (Adjusted)	$4.2B	$5.4B	$4.9B	$3.7B	$4.1B

Period Ending	2021-09-30 FY-4	2022-09-30 FY-3	2023-09-30 FY-2	2024-09-30 FY-1	2025-09-30 Current FY
Revenue	$7.7B	$7.2B	$7.2B	$7.9B	$7.5B
Revenue Growth (YoY)	3.25%	-5.58%	-0.42%	9.21%	-4.25%

Cost of Revenues	$3.4B	$3.2B	$4B	$3.6B	$4B
Gross Profit	$4.2B	$4B	$3.2B	$4.3B	$3.6B
Gross Profit Margin	55.2%	55.32%	44.03%	54.36%	47.41%

R&D Expenses	$1.2B	$1.1B	$1.3B	$1.2B	$1.1B
Selling, General & Admin	$1.9B	$1.8B	$1.7B	$1.8B	$1.7B
Other Inc / (Exp)	-$28.8M	-$6.3M	$14M	-$605.4M	--
Operating Expenses	$3.1B	$2.9B	$3B	$3B	$2.8B
Operating Income	$1.1B	$1.1B	$154.7M	$1.3B	$763.2M

Net Interest Expenses	$360.4M	$388.9M	$401.4M	$458.7M	$563.8M
EBT. Incl. Unusual Items	$587M	$472.9M	-$678M	$803.5M	$205.1M
Earnings of Discontinued Ops.	--	--	--	--	--
Income Tax Expense	$140.4M	$20.4M	-$332.1M	$182.7M	$270.6M
Net Income to Company	$413.6M	$431.8M	-$358M	$594.6M	-$84.5M

Minority Interest in Earnings	$281.6K	-$72.3K	$408.1K	$408.8K	$488.2K
Net Income to Common Excl Extra Items	$417.8M	$446.3M	-$331.8M	$617.2M	-$79.5M

Basic EPS (Cont. Ops)	$0.13	$0.14	-$0.11	$0.19	-$0.03
Diluted EPS (Cont. Ops)	$0.13	$0.14	-$0.11	$0.19	-$0.03
Weighted Average Basic Share	$3.1B	$3.1B	$3.1B	$3.2B	$3.2B
Weighted Average Diluted Share	$3.2B	$3.1B	$3.1B	$3.2B	$3.2B

EBITDA	$2.4B	$2.3B	$1.8B	$2.6B	$2.2B
EBIT	$1.1B	$1.1B	$154.7M	$1.3B	$763.2M

Revenue (Reported)	$7.7B	$7.2B	$7.2B	$7.9B	$7.5B
Operating Income (Reported)	$1.1B	$1.1B	$154.7M	$1.3B	$763.2M
Operating Income (Adjusted)	$1.1B	$1.1B	$154.7M	$1.3B	$763.2M

Period Ending	2021-09-30 FY-4	2022-09-30 FY-3	2023-09-30 FY-2	2024-09-30 FY-1	2025-09-30 Current FY
Revenue	$31.6B	$30.2B	$29.9B	$30.2B	$29.6B
Revenue Growth (YoY)	--	--	--	--	--

Cost of Revenues	$13.4B	$14B	$14B	$14.1B	$14.5B
Gross Profit	$18.2B	$16.2B	$15.9B	$16.2B	$15.1B
Gross Profit Margin	--	--	--	--	--

R&D Expenses	$4.5B	$4.6B	$4.9B	$4.8B	$4.6B
Selling, General & Admin	$8.3B	$7.5B	$7.3B	$7.3B	$7.2B
Other Inc / (Exp)	$872.3M	-$1B	-$654.2M	-$661.6M	--
Operating Expenses	$12.8B	$12.1B	$12.2B	$12.1B	$11.8B
Operating Income	$5.4B	$4.1B	$3.6B	$4B	$3.3B

Net Interest Expenses	$2.3B	$1.4B	$1.7B	$1.6B	$1.8B
EBT. Incl. Unusual Items	$4.8B	$1.9B	$1.5B	$1.7B	$738.6M
Earnings of Discontinued Ops.	--	--	--	--	--
Income Tax Expense	$461.2M	$168.5M	$41.6M	-$153M	$442.3M
Net Income to Company	$4.4B	$1.6B	$1.4B	$1.9B	$276.9M

Minority Interest in Earnings	$1.9M	$283.9K	$658.8K	$1.1M	$1.4M
Net Income to Common Excl Extra Items	$4.4B	$1.7B	$1.4B	$1.9B	$260.5M

Basic EPS (Cont. Ops)	$1.41	$0.54	$0.45	$0.61	$0.08
Diluted EPS (Cont. Ops)	$1.40	$0.53	$0.44	$0.60	$0.08
Weighted Average Basic Share
Weighted Average Diluted Share

EBITDA	$10.6B	$9.1B	$9B	$9.1B	$8.4B
EBIT	$5.4B	$4.1B	$3.6B	$4B	$3.3B

Revenue (Reported)	$31.6B	$30.2B	$29.9B	$30.2B	$29.6B
Operating Income (Reported)	$5.4B	$4.1B	$3.6B	$4B	$3.3B
Operating Income (Adjusted)	$5.4B	$4.1B	$3.6B	$4B	$3.3B

Period Ending	2021-09-30 FY-4	2022-09-30 FY-3	2023-09-30 FY-2	2024-09-30 FY-1	2025-09-30 Current FY
Revenue	$16.4B	$14.7B	$14.9B	$15.6B	$15.2B
Revenue Growth (YoY)	--	--	--	--	--

Cost of Revenues	$6.6B	$6.5B	$7.3B	$7.1B	$7.5B
Gross Profit	$9.8B	$8.2B	$7.6B	$8.5B	$7.7B
Gross Profit Margin	--	--	--	--	--

R&D Expenses	$2.3B	$2.2B	$2.5B	$2.3B	$2.1B
Selling, General & Admin	$3.9B	$3.6B	$3.6B	$3.5B	$3.5B
Other Inc / (Exp)	-$32M	-$10.1M	$11M	-$610M	-$3.7M
Operating Expenses	$6.3B	$5.8B	$6B	$5.8B	$5.6B
Operating Income	$3.5B	$2.4B	$1.6B	$2.7B	$2.1B

Net Interest Expenses	$1B	$816.2M	$834.5M	$841.8M	$1.3B
EBT. Incl. Unusual Items	$2.6B	$1.7B	$306.9M	$1.7B	$1.3B
Earnings of Discontinued Ops.	--	--	--	--	--
Income Tax Expense	$919.6M	$408.9M	-$352.5K	$447.8M	$453M
Net Income to Company	$1.7B	$1.2B	$292.1M	$1.2B	$775.6M

Minority Interest in Earnings	$674.7K	-$18.4K	$488.1K	$736.1K	$737.4K
Net Income to Common Excl Extra Items	$1.7B	$1.3B	$318.2M	$1.2B	$780.6M

Basic EPS (Cont. Ops)	$0.53	$0.41	$0.10	$0.39	$0.25
Diluted EPS (Cont. Ops)	$0.53	$0.40	$0.10	$0.38	$0.25
Weighted Average Basic Share	$6.3B	$6.2B	$6.2B	$6.3B	$6.3B
Weighted Average Diluted Share	$6.3B	$6.2B	$6.3B	$6.4B	$6.3B

EBITDA	$6.1B	$4.9B	$4.5B	$5.2B	$4.7B
EBIT	$3.5B	$2.4B	$1.6B	$2.7B	$2.1B

Revenue (Reported)	$16.4B	$14.7B	$14.9B	$15.6B	$15.2B
Operating Income (Reported)	$3.5B	$2.4B	$1.6B	$2.7B	$2.1B
Operating Income (Adjusted)	$3.5B	$2.4B	$1.6B	$2.7B	$2.1B

Period Ending	2021-03-31 FY-4	2022-03-31 FY-3	2023-03-31 FY-2	2024-03-31 FY-1	2025-03-31 Current FY
Cash and Equivalents	$8.7B	$7B	$4B	$3B	$2.6B
Short Term Investments	$331.8M	$207.3M	$151.4M	$99.7M	$136.8M
Accounts Receivable, Net	$6.4B	$5.1B	$4.3B	$4B	$4.4B
Inventory	$6.8B	$7B	$7.4B	$8B	$8.1B
Prepaid Expenses	--	--	--	--	--
Other Current Assets	$1.1B	$1.2B	$1.2B	$1.1B	$1.1B
Total Current Assets	$24.6B	$21.4B	$18B	$16.9B	$16.9B

Property Plant And Equipment	$13.2B	$13B	$12.7B	$13.1B	$13.2B
Long-Term Investments	$3.2B	$2.7B	$2.8B	$2.8B	$2.4B
Goodwill	$36.6B	$36.1B	$36B	$35.7B	$35.6B
Other Intangibles	$35.4B	$31.3B	$32B	$28.2B	$24.3B
Other Long-Term Assets	$909.6M	$676.8M	$475.3M	$338.4M	$469.7M
Total Assets	$116.9B	$108.6B	$104.9B	$99.8B	$95.3B

Accounts Payable	$2.1B	$2.4B	$2.3B	$2.1B	$2.1B
Accrued Expenses	--	--	--	--	--
Current Portion Of Long-Term Debt	$200.8M	$1.7B	$2.5B	$2.4B	$3.7B
Current Portion Of Capital Lease Obligations	--	--	--	--	--
Other Current Liabilities	$7.2B	$6.4B	$5.6B	$5B	$5.4B
Total Current Liabilities	$16B	$17.7B	$18.6B	$15.3B	$16.8B

Long-Term Debt	$45.2B	$37.5B	$33.5B	$33.2B	$29.9B
Capital Leases	--	--	--	--	--
Total Liabilities	$70B	$61.7B	$57.1B	$51.8B	$48.9B

Common Stock	$15.1B	$13.8B	$12.6B	$11.1B	$11.3B
Other Common Equity Adj	--	--	--	--	--
Common Equity	$46.8B	$46.8B	$47.7B	$48.1B	$46.4B
Total Preferred Equity	--	--	--	--	--
Minority Interest, Total	$37.5M	$4.2M	$4.1M	$4.9M	$6M
Total Equity	$46.9B	$46.8B	$47.7B	$48.1B	$46.4B

Total Liabilities and Equity	$116.9B	$108.6B	$104.9B	$99.8B	$95.3B
Cash and Short Terms	$8.7B	$7B	$4B	$3B	$2.6B
Total Debt	$45.7B	$38B	$34B	$33.7B	$30.4B

Period Ending	2021-09-30 FY-4	2022-09-30 FY-3	2023-09-30 FY-2	2024-09-30 FY-1	2025-09-30 Current FY
Cash and Equivalents	$5.4B	$5.5B	$2.1B	$6B	$4.6B
Short Term Investments	$230M	$221M	$105.5M	$330.5M	--
Accounts Receivable, Net	$7.6B	$5.2B	$5.1B	$4.9B	$4.7B
Inventory	$7B	$6.6B	$7.7B	$8.4B	$8.8B
Prepaid Expenses	--	--	--	--	--
Other Current Assets	$1.2B	$1.1B	$1.2B	$1.1B	--
Total Current Assets	$22B	$19B	$16.5B	$21.4B	$19.8B

Property Plant And Equipment	$13.1B	$12.2B	$12.7B	$13.2B	$13.4B
Long-Term Investments	$3.2B	$2.9B	$2.8B	$1.9B	$2.5B
Goodwill	$36.4B	$34.6B	$35.5B	$36.1B	--
Other Intangibles	$33.8B	$29B	$29.5B	$26.4B	--
Other Long-Term Assets	$842.3M	$558.6M	$399.4M	$595.3M	--
Total Assets	$112.6B	$100.8B	$99.7B	$101.9B	$98B

Accounts Payable	$3B	$2.7B	$2.8B	$2.9B	$3B
Accrued Expenses	--	--	--	--	--
Current Portion Of Long-Term Debt	$1.9B	$3.9B	$1.8B	$4.4B	--
Current Portion Of Capital Lease Obligations	--	--	--	--	--
Other Current Liabilities	$6.8B	$5.3B	$5.9B	$4.9B	--
Total Current Liabilities	$17.2B	$16.5B	$15.9B	$16.7B	$14.5B

Long-Term Debt	$36B	$28.8B	$29.5B	$31B	$29.5B
Capital Leases	--	--	--	--	--
Total Liabilities	$64.9B	$54.4B	$52.3B	$53.5B	$49.7B

Common Stock	$15B	$11.6B	$11.2B	$11.8B	$11.5B
Other Common Equity Adj	--	--	--	--	--
Common Equity	--	--	--	--	--
Total Preferred Equity	--	--	--	--	--
Minority Interest, Total	$3.8M	$3.9M	$4.5M	$5.9M	$6.7M
Total Equity	$47.7B	$46.4B	$47.4B	$48.4B	$48.3B

Total Liabilities and Equity	$112.6B	$100.8B	$99.7B	$101.9B	$98B
Cash and Short Terms	$5.4B	$5.5B	$2.1B	$6B	$4.6B
Total Debt	$36B	$28.8B	$29.5B	$31B	$29.5B

Period Ending	2021-03-31 FY-4	2022-03-31 FY-3	2023-03-31 FY-2	2024-03-31 FY-1	2025-03-31 Current FY
Net Income to Stockholders	$3.5B	$2B	$2.3B	$998.1M	$709.4M
Depreciation & Amoritzation	$5.3B	$5.2B	$4.9B	$5B	$5B
Stock-Based Compensation	$355.1M	$386M	$447.7M	$490.1M	$478M
Change in Accounts Receivable	-$87.8M	$1.1B	$554.4M	$104.5M	-$386.7M
Change in Inventories	$244.9M	-$410.7M	-$584.1M	-$800.4M	-$229.4M
Cash From Operations	$8.5B	$9.1B	$6.5B	$4.4B	$6.3B

Capital Expenditures	$2.2B	$1.7B	$4.7B	$3.3B	$2.3B
Cash Acquisitions	--	$442M	--	$230.3M	--
Cash From Investing	$3.7B	-$1.8B	-$4.5B	-$3.4B	-$2.5B

Dividends Paid (Ex Special Dividend)	$2.7B	$2.5B	$2.1B	$2B	$2B
Special Dividend Paid
Long-Term Debt Issued	$11.1B	$2.2B	$851.6M	$2.6B	$6.9B
Long-Term Debt Repaid	-$16B	-$7.6B	-$3B	-$2.6B	-$9B
Repurchase of Common Stock	$20.2M	$689.9M	$198.7M	$16.1M	$340.2M
Other Financing Activities	-$330.2M	-$3.4M	-$68M	$235.3M	$198.5M
Cash From Financing	-$9.2B	-$8.6B	-$4.4B	-$1.8B	-$4.2B

Beginning Cash (CF)	$8.7B	$7B	$1.7B	$1.4B	$1.6B
Foreign Exchange Rate Adjustment	--	--	--	--	--
Additions / Reductions	$3.1B	-$1B	-$2.3B	-$523.7M	-$476.8M
Ending Cash (CF)	$12B	$6.2B	-$439M	$1B	$1B

Levered Free Cash Flow	$6.3B	$7.4B	$1.8B	$1.1B	$4B

Period Ending	2021-09-30 FY-4	2022-09-30 FY-3	2023-09-30 FY-2	2024-09-30 FY-1	2025-09-30 Current FY
Net Income to Stockholders	$413.6M	$431.8M	-$358M	$594.6M	-$84.5M
Depreciation & Amoritzation	$1.3B	$1.2B	$1.2B	$1.2B	$1.3B
Stock-Based Compensation	$112.8M	$123.6M	$127.2M	$139M	$128.6M
Change in Accounts Receivable	-$120M	$94.4M	$142M	-$65.5M	-$68.9M
Change in Inventories	-$35.2M	-$47.2M	-$341.5M	-$265M	-$199.2M
Cash From Operations	$1.9B	$1.4B	$1.2B	$1.7B	$2.4B

Capital Expenditures	$394.4M	$276.3M	$433.8M	$393.1M	$361.9M
Cash Acquisitions	-$1M	--	--	--	--
Cash From Investing	-$313.1M	-$201.7M	-$386.7M	-$518M	-$352.7M

Dividends Paid (Ex Special Dividend)	$82M	$49.1M	$34.8M	$61.8M	$56.3M
Special Dividend Paid	--	--	--	--	--
Long-Term Debt Issued	-$9.1K	--	-$36.5M	$3.4B	--
Long-Term Debt Repaid	-$1.9B	-$60.2M	-$1B	-$1.6B	--
Repurchase of Common Stock	-$94K	-$7.1M	-$517.6K	$35.8K	-$1.5M
Other Financing Activities	-$118.1K	-$180.6K	$384.9M	-$16.7M	--
Cash From Financing	-$2B	-$112.6M	-$772.2M	-$529.3M	$168.6M

Beginning Cash (CF)	$5.4B	$5.5B	$2.1B	$6B	$4.6B
Foreign Exchange Rate Adjustment	$587.2K	$70.3M	$24.9M	-$268.6M	$92.2M
Additions / Reductions	-$416.7M	$1.2B	$60.1M	$354.2M	$2.3B
Ending Cash (CF)	$5B	$6.8B	$2.2B	$6.1B	$7B

Levered Free Cash Flow	$1.5B	$1.2B	$760.4M	$1.3B	$2B

Period Ending	2021-09-30 FY-4	2022-09-30 FY-3	2023-09-30 FY-2	2024-09-30 FY-1	2025-09-30 Current FY
Net Income to Stockholders	$4.4B	$1.6B	$1.4B	$1.9B	$276.9M
Depreciation & Amoritzation	$5.3B	$5.1B	$5B	$5B	$5B
Stock-Based Compensation	$380.1M	$414.7M	$471M	$487.7M	$481.9M
Change in Accounts Receivable	-$576.7M	$1.6B	$85.8M	$247.5M	$250.1M
Change in Inventories	-$8.2M	-$302.2M	-$1B	-$579.6M	-$188.8M
Cash From Operations	$8.6B	$7.8B	$6.3B	$5.4B	$7.4B

Capital Expenditures	$2.3B	$1.9B	$6.1B	$2.2B	$1.9B
Cash Acquisitions	$250.8M	$192.8M	--	$230M	--
Cash From Investing	$2.5B	-$1.8B	-$6B	-$2.6B	-$1.6B

Dividends Paid (Ex Special Dividend)	$2.7B	$2.3B	$2B	$1.9B	$2.1B
Special Dividend Paid
Long-Term Debt Issued	$12.7M	$2.2B	$1.5B	$8.5B	--
Long-Term Debt Repaid	-$7.2B	-$3.7B	-$4.5B	-$2.8B	--
Repurchase of Common Stock	$23.6M	$869.6M	$15.7M	$11.8M	$682.8M
Other Financing Activities	--	-$3.6M	$286.2M	$135.7M	--
Cash From Financing	-$11.4B	-$4.7B	-$3.9B	$894.2M	-$7B

Beginning Cash (CF)	--	--	--	--	--
Foreign Exchange Rate Adjustment	--	--	--	--	--
Additions / Reductions	-$74.1M	$1.8B	-$3.5B	$3.6B	-$1B
Ending Cash (CF)	--	--	--	--	--

Levered Free Cash Flow	$6.3B	$5.9B	$280.1M	$3.2B	$5.5B

Period Ending	2021-09-30 FY-4	2022-09-30 FY-3	2023-09-30 FY-2	2024-09-30 FY-1	2025-09-30 Current FY
Net Income to Stockholders	$1.7B	$1.2B	$292.1M	$1.2B	$775.6M
Depreciation & Amoritzation	$2.6B	$2.4B	$2.5B	$2.5B	$2.5B
Stock-Based Compensation	$190.9M	$218.2M	$239.5M	$237.8M	$243M
Change in Accounts Receivable	-$502.4M	-$44M	-$515.1M	-$371.9M	$263.9M
Change in Inventories	-$227.3M	-$117.4M	-$549.3M	-$329.7M	-$289.7M
Cash From Operations	$3.2B	$1.9B	$1.7B	$2.7B	$3.8B

Capital Expenditures	$781M	$1B	$2.4B	$1.3B	$881.4M
Cash Acquisitions	$250.8M	--	--	--	--
Cash From Investing	-$961.5M	-$935.9M	-$2.3B	-$1.6B	-$617.7M

Dividends Paid (Ex Special Dividend)	$1.3B	$1B	$985.4M	$948.1M	$1.1B
Special Dividend Paid	--	--	--	--	--
Long-Term Debt Issued	--	--	$692.3M	$6.6B	$1.3B
Long-Term Debt Repaid	-$4.2B	-$346.7M	-$1.9B	-$2.1B	-$1.3B
Repurchase of Common Stock	$23.1M	$200.3M	$16.4M	$12.1M	$355.6M
Other Financing Activities	-$118.1K	-$304K	$353.9M	$254.2M	-$9.2M
Cash From Financing	-$5.5B	-$1.6B	-$1B	$1.6B	-$1.2B

Beginning Cash (CF)	$11.3B	$10.3B	$4.3B	$11B	$7B
Foreign Exchange Rate Adjustment	$31M	$243.4M	$132.2M	-$158.1M	$75.3M
Additions / Reductions	-$3.3B	-$383.6M	-$1.5B	$2.6B	$2B
Ending Cash (CF)	$8.1B	$10.1B	$2.9B	$13.4B	$9.2B

Levered Free Cash Flow	$2.4B	$873.5M	-$651.5M	$1.4B	$2.9B

Related Companies

Get TAK Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

TAK

Sector

P/E ratio

197.72x

23.89x

PEG ratio

5.54x

-0.01x

P/B ratio

1.02x

1.82x

Price / LTM sales

1.68x

1.60x

Growth Metrics

TAK

Sector

Revenue growth

-4.25%

4.62%

Earnings growth

-113.21%

10.88%

Revenue (5-year growth)

-0.14%

6.5%

Earnings forecast

--

-$0.21

Profitability

TAK

Sector

Profitability FY 2024

$16.1B

$3.5M

Return on invested capital

0.33%

-31.77%

Return on assets

0.27%

-27.96%

Return on equity

0.55%

-37.63%

Earnings Date

Last Earnings Date

Oct

30

Next Earnings Date

Jan

29

Estimated Next Earnings Date

Jan

29

Balance Sheet

TAK

Sector

Total cash

$4.6B

$26.3M

Short term investments

$136.8M

$25.7M

Total assets

$95.3B

$78M

Long term debt

$29.5B

$3.3M

Stock Ideas

Buy

57

Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy or Sell?

Buy

55

Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy or Sell?

Buy

61

Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Buy or Sell?

Alerts

Buy

80

TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy or Sell?

Buy

68

KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy or Sell?

Buy

64

ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

TAK Quote, Financials, Valuation and Earnings

Related Companies

Get TAK Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?

Is SentinelOne Stock Undervalued?

Is Broadcom Stock on Sale?